Standout Papers

Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma 2006 2026 2012 2019 1.0k
  1. Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma (2007)
    Meletios Α. Dimopoulos, Andrew Spencer et al. New England Journal of Medicine
  2. Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America (2007)
    Donna M. Weber, Christine Chen et al. New England Journal of Medicine
  3. Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion (2006)
    Alan F. List, Gordon W. Dewald et al. New England Journal of Medicine

Immediate Impact

4 by Nobel laureates 34 from Science/Nature 64 standout
Sub-graph 1 of 20

Citing Papers

Early detection of cancer
2022 StandoutScience
Multiple myeloma
2021 Standout
1 intermediate paper

Works of John Patin being referenced

Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America
2007 Standout
Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma
2007 Standout

Author Peers

Author Last Decade Papers Cites
John Patin 291 2662 1786 1232 12 3.3k
Sue Bell 65 3050 2275 2075 67 4.2k
Marie Joseph 52 991 2309 887 16 3.3k
Harald Gschaidmeier 100 1996 1025 858 54 4.3k
Bethan Psaila 86 2068 1827 1498 59 5.4k
M. H. van Rijswijk 243 1595 1047 513 63 6.7k
Koji Shido 39 1506 2396 841 32 5.4k
Josef S Smolen 66 1510 1107 742 23 6.2k
Zhinuan Yu 20 3786 3046 2414 52 4.3k
Wim van Putten 21 2015 1356 591 26 3.3k
Christopher D. Turner 77 612 762 502 66 2.5k

All Works

Loading papers...

Rankless by CCL
2026